They said the loss decreased when it increased from $11m to $19m. They keep making these kinds of errors. For a $20m company, $19m is an shocking loss. And there was only $700k cash at the end of the quarter. I've only skimmed this report, so can anyone see which bit might relate to the failed $10m clinical trial from last year? Directors were unclear about it at the EGM.
Ann: Appendix 4E, page-2
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
